Niki BioSolutions NIKI
NASDAQ NIKI
$4.81 -0.09 (-1.83%)
As of: Oct 1, 2026 · 2:11 PM EDT

Niki BioSolutions (NIKI) Operating Margin (2024 - 2025)

Updated

Niki BioSolutions' Operating Margin was -293.17% in FY2025.

Analysis

Niki BioSolutions (NIKI) Operating Margin (2024 - 2025) Analysis & Trends

From FY2022 onward, Niki BioSolutions has reported Operating Margin for 4 years.

  • Operating Margin shows a three-year change of -1750.47 percentage points (FY2022 to FY2025).
  • Per Business Quant data, Operating Margin in earlier years was -34.21% in FY2024, 2588.49% in FY2023 (+1131.19 pp) and 1457.31% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Niki BioSolutions 2.67 Mn 2.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -575.40%
Nov 30, 2024 -35.35%
Aug 31, 2024 -71.86%
API Access

Niki BioSolutions Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=NIKI&period=max&api_key=YOUR_API_KEY